We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Short Communication

First detection and characterization of EV-A71 and a new genogroup of CVA-24 causing neurological disease in Tunisia

    Ines Othman

    *Author for correspondence: Tel.: +216 9653 9796;

    E-mail Address: Ines_othman@yahoo.fr

    Faculty of Pharmacy, LR99-ES27, Monastir, Tunisia

    ,
    Ichrak Slama

    Faculty of Pharmacy, LR99-ES27, Monastir, Tunisia

    ,
    Maha Mastouri

    Faculty of Pharmacy, LR99-ES27, Monastir, Tunisia

    Fattouma Bourguiba University Hospital, Laboratory of Microbiology, Monastir, Tunisia

    ,
    Jean-Luc Bailly

    Université Clermont Auvergne, Faculty of Pharmacy, LMGE CNRS 6023, Clermont-Ferrand, 63001, France

    &
    Mahjoub Aouni

    Faculty of Pharmacy, LR99-ES27, Monastir, Tunisia

    Published Online:https://doi.org/10.2217/fvl-2021-0284

    Aim: Molecular characterization of enterovirus A71 (EV-A71) and coxsackievirus A24 (CVA-24) strains isolated during neurological diseases surveillance activities in Tunisian patients. Materials & methods: Specimens were obtained from two Tunisian children and analyzed for enterovirus with quantitative reverse transcription PCR (RT-qPCR). We sequenced the whole genome of strains detected. Results: The EV-A71 sequence reported was assigned to subgenogroup C2 with a high nucleotide sequence identity to other EV-A71 C2 detected in other countries, which suggests virus migration. Interestingly, in the VP1 coding region, the Tunisian CV-A24 strain displayed high sequence divergence from other CV-A24, which confirms that it represents a new genogroup. Conclusion: This is the first report of EV-A71 in Tunisia and the first report of a CV-A24 strain causing aseptic meningitis.

    References

    • 1. International Union of Microbiological Societies Virology Division. Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses. King AMLefkowitz EAdams MJCarstens EB (Eds). Elsevier, 9, 835–839 (2011).
    • 2. Oberste MS, Penaranda S, Maher K, Pallansch MA. Complete genome sequences of all members of the species human enterovirus A. J. Gen. Virol. 85(6), 1597–1607 (2004).
    • 3. Wang J, Zhang Y, Hong M et al. Isolation and characterization of a Chinese strain of human enterovirus 74 from a healthy child in the Tibet Autonomous Region of China. Arch. Virol. 157(8), 1593–1598 (2012).
    • 4. Kupila L, Vuorinen T, Vainionpää R, Hukkanen V, Marttila RJ, Kotilainen P. Etiology of aseptic meningitis and encephalitis in an adult population. Neurology 66(1), 75–80 (2006).
    • 5. Michos AG, Syriopoulou VP, Hadjichristodoulou C et al. Aseptic meningitis in children: analysis of 506 cases. PLOS ONE 2(8), e674 (2007).
    • 6. Nahdi I, Boukoum H, Nabil Ben Salem A et al. Detection of herpes simplex virus (1 and 2), varicella-zoster virus, cytomegalovirus, human herpesvirus 6 and enterovirus in immunocompetent Tunisian patients with acute neuromeningeal disorder. J. Med. Virol. 84(2), 282–289 (2012).
    • 7. Oh M, Park S, Choi Y et al. Acute hemorrhagic conjunctivitis caused by coxsackievirus A24 variant, South Korea, 2002. Emerg. Infect. Dis. 9(8), 1010 (2003).
    • 8. Triki H, Rezig D, Bahri O et al. Molecular characterisation of a coxsackievirus A24 that caused an outbreak of acute haemorrhagic conjunctivitis, Tunisia 2003. Clin. Microbiol. Infect. 13(2), 176–182 (2007).
    • 9. Chu P-Y, Ke G-M, Chang C-H et al. Molecular epidemiology of coxsackie A type 24 variant in Taiwan, 2000–2007. J. Clin. Virol. 45(4), 285–291 (2009).
    • 10. Wang J, Hu Y, Zheng M. “Enterovirus A71 antivirals: past, present, and future.” Acta Pharm. Sin. B 12(4), 1542–1566 (2022).
    • 11. Huang S-W, Cheng D, Wang J-R. Enterovirus A71: virulence, antigenicity, and genetic evolution over the years. J. Biomed. Sci. 26(1), 1–9 (2019).
    • 12. Ho M, Chen E-R, Hsu K-H et al. An epidemic of enterovirus 71 infection in Taiwan. N. Engl. J. Med. 341(13), 929–935 (1999).
    • 13. Chan LG, Parashar UD, Lye MS et al. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. Clin. Infect. Dis. 31(3), 678–683 (2000).
    • 14. McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, Cardosa MJ. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J. Virol. 75(16), 7732–7738 (2001).
    • 15. Wang J-R, Tuan Y-C, Tsai H-P, Yan J-J, Liu C-C, Su I-J. Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J. Clin. Microbiol. 40(1), 10–15 (2002).
    • 16. Chan KP, Goh KT, Chong CY, Teo ES, Lau G, Ling AE. Epidemic hand foot and mouth disease caused by human enterovirus 71, Singapore. Emerg. Infect. Dis. 9(1), 78 (2003).
    • 17. Shimizu H, Utama A, Onnimala N et al. Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr. Int. 46(2), 231–235 (2004).
    • 18. Zhang Y, Tan X-J, Wang H-Y et al. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J. Clin. Virol. 44(4), 262–267 (2009).
    • 19. Puenpa J, Wanlapakorn N, Vongpunsawad S, Poovorawan Y. The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia-Pacific region. J. Biomed. Sci. 26(1), 1–11 (2019).
    • 20. Hong NTT, Nguyet LA, Ny NTH et al. Severe enterovirus A71 associated hand, foot and mouth disease, Vietnam, 2018: preliminary report of an impending outbreak. Euro Surveill. 23(46), 1800590 (2018).
    • 21. Volle R, Nourrisson C, Mirand A et al. Quantitative real-time RT-PCR assay for research studies on enterovirus infections in the central nervous system. J. Virol. Methods 185(1), 142–148 (2012).
    • 22. Oberste MS, Maher K, Kilpatrick DR, Flemister MR, Brown BA, Pallansch MA. Typing of human enteroviruses by partial sequencing of VP1. J. Clin. Microbiol. 37(5), 1288–1293 (1999).
    • 23. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mole. Biol. Evol. 28(10), 2731–2739 (2011).
    • 24. Tamura K, Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mole. Biol. Evol. 10(3), 512–526 (1993).
    • 25. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39(4), 783–791 (1985).
    • 26. Salminen MO, Carr JK, Burke DS, McCutchan FE. Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res. Hum. Retrovir. 11(11), 1423–1425 (1995).
    • 27. Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mole. Biol. Evol. 29(8), 1969–1973 (2012).
    • 28. Othman I, Mirand A, Slama I et al. Enterovirus migration patterns between France and Tunisia. PLOS ONE 10(12), e0145674 (2015).
    • 29. Mirand A, Henquell C, Archimbaud C et al. Prospective identification of enteroviruses involved in meningitis in 2006 through direct genotyping in cerebrospinal fluid. J. Clin. Microbiol. 46(1), 87–96 (2008).
    • 30. Huizing KM, Swanink CM, Landstra AM, van Zwet AA, van Setten PA. Rapid enterovirus molecular testing in cerebrospinal fluid reduces length of hospitalization and duration of antibiotic therapy in children with aseptic meningitis. Pediatr. Infect. Dis. J. 30(12), 1107–1109 (2011).
    • 31. Archimbaud C, Chambon M, Bailly JL et al. Impact of rapid enterovirus molecular diagnosis on the management of infants, children, and adults with aseptic meningitis. J. Med. Virol. 81(1), 42–48 (2009).
    • 32. El Hiar R, Haddad S, Jaïdane H et al. Enteroviral central nervous system infections in children of the region of Monastir, Tunisia: diagnosis, laboratory findings of cerebrospinal fluid and clinical manifestations. Indian J. Virol. 23(3), 294–302 (2012).
    • 33. Othman I, Volle R, Elargoubi A et al. Enterovirus meningitis in Tunisia (Monastir, Mahdia, 2011–2013): identification of virus variants cocirculating in France. Diagn. Microbiol. Infect. Dis. 84(2), 116–122 (2016).
    • 34. Sghaier W, Bahri O, Kedous E et al. Étude rétrospective des étiologies virales des infections neuroméningées en Tunisie (2003–2009). Méd. Santé Trop. 22(4), 373–378 (2012).
    • 35. Gharbi J, Jaïdane H, M'hadheb MB et al. Epidemiological study of non-polio enterovirus neurological infections in children in the region of Monastir, Tunisia. Diagn. Microbiol. Infect. Dis. 54(1), 31–36 (2006).
    • 36. Bahri O, Rezig D, Nejma-Oueslati BB et al. Enteroviruses in Tunisia: virological surveillance over 12 years (1992–2003). J. Med. Microbiol. 54(1), 63–69 (2005).
    • 37. Smura T, Blomqvist S, Vuorinen T et al. The evolution of Vp1 gene in enterovirus C species sub-group that contains types CVA-21, CVA-24, EV-C95, EV-C96 and EV-C99. PLOS ONE 9(4), e93737 (2014).
    • 38. Chansaenroj J, Vongpunsawad S, Puenpa J et al. Epidemic outbreak of acute haemorrhagic conjunctivitis caused by coxsackievirus A24 in Thailand, 2014. Epidemiol. Infect. 143(14), 3087–3093 (2015).
    • 39. Rico-Hesse R, Pallansch MA, Nottay BK, Kew OM. Geographic distribution of wild poliovirus type 1 genotypes. Virology 160(2), 311–322 (1987).
    • 40. van der Sanden S, van der Avoort H, Lemey P, Uslu G, Koopmans M. Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C viruses. J. Gen. Virol. 91(8), 1949–1958 (2010).
    • 41. Chakraborty R, Iturriza-Gómara M, Musoke R, Palakudy T, D'Agostino A, Gray J. An epidemic of enterovirus 71 infection among HIV-1-infected orphans in Nairobi. AIDS 18(14), 1968–1970 (2004).
    • 42. Sadeuh-Mba SA, Bessaud M, Massenet D et al. High frequency and diversity of species C enteroviruses in Cameroon and neighboring countries. J. Clin. Microbiol. 51(3), 759–770 (2013).
    • 43. Faleye TOC, Adewumi MO, Coker BA, Nudamajo FY, Adeniji JA. Direct detection and identification of enteroviruses from faeces of healthy Nigerian children using a cell-culture independent RT-seminested PCR assay. Adv.Virol. 2016, 1–12 (2016).
    • 44. Antona D, Kossorotoff M, Schuffenecker I et al. Severe paediatric conditions linked with EV-A71 and EV-D68, France, May to October 2016. Euro Surveill. 21(46), 30402 (2016).
    • 45. European Centre for Disease Prevention and Control. Rapid risk assessment, enterovirus detections associated with severe neurological symptoms in children and adults in European countries, 8 August 2016. http://ecdc.europa.eu/en/publications/Publications/01–08–2016-RRA-Enterovirus
    • 46. Karrasch M, Fischer E, Scholten M et al. A severe pediatric infection with a novel enterovirus A71 strain, Thuringia, Germany. J. Clin. Virol. 84, 90–95 (2016).